Perspectives

Our perspectives on the problems life sciences cannot afford to get wrong.

Filter

Topics

Portfolio & Pipeline Management

| Intended Reader Biopharma leaders | Key Takeaways GLP-1 drugs inspire broader therapeutic advancements. Long-lasting …

| Intended Reader Life science, pharmaceutical, and biotech companies exploring precision medicines Pioneering gene and …

| Key Takeaways M&A activity is increasing as companies look for new products and revenue streams, and the pace of …